Dr. J gave us the "any ICI" answer for our mTNBC ?
Post# of 157773

" These patients, currently ineligible for ICI therapy, will receive leronlimab plus standard chemotherapy, followed by a regimen of leronlimab with an ICI. We look forward to sharing more details after the FDA review of the protocol..."
It will be whatever ICI the patient previously failed on. Just like the April 2025 lady was re-dosed with Keytruda. Re-dosing the same ICI is an outstanding way for LL to be proven to the entire ICI industry. A multiple of -- "proof is in the pudding....Leronlimab simply followed you & expanded your potential".
What will our protocol look like:
Brain, Lung, Kidney & ???
If all correct -- wow, the potential.

